Susan V Di Meo

Title: Susan V Di Meo: Innovator in Cancer Treatment

Introduction

Susan V Di Meo is a prominent inventor based in New City, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic agents. With a total of 4 patents, her work focuses on the synthesis of compounds that inhibit cell proliferation, particularly in cancerous cells.

Latest Patents

One of her latest patents is titled "Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents." This invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones, which are potent inhibitors of cyclin dependent kinases (cdk1-7) and their regulatory subunits known as cyclins A-G. The invention also provides a novel method for treating cancer or other proliferative diseases by administering a therapeutically effective amount of these compounds or their pharmaceutically acceptable salt forms. Additionally, it outlines methods for treating cancer through a combination of these compounds and other known anti-cancer agents.

Career Highlights

Throughout her career, Susan has worked with leading pharmaceutical companies, including Bristol-Myers Squibb Pharma Company and DuPont Pharmaceuticals Company. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer treatment.

Collaborations

Susan has collaborated with notable professionals in her field, including David J Carini and Eddy W Yue. These partnerships have further enhanced her research and development efforts, leading to impactful innovations in cancer therapies.

Conclusion

Susan V Di Meo is a trailblazer in the field of cancer treatment, with a focus on developing effective therapeutic agents. Her innovative patents and collaborations with industry leaders underscore her commitment to advancing medical science and improving patient outcomes.